相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。miR-221-3p Regulates VEGFR2 Expression in High-Risk Prostate Cancer and Represents an Escape Mechanism from Sunitinib In Vitro
Markus Krebs et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Tumor-derived exosomal miR-619-5p promotes tumor angiogenesis and metastasis through the inhibition of RCAN1.4
Dong Ha Kim et al.
CANCER LETTERS (2020)
Exosomal MALAT1 sponges miR-26a/26b to promote the invasion and metastasis of colorectal cancer via FUT4 enhanced fucosylation and PI3K/Akt pathway
Jingchao Xu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
被撤回的出版物: MicroRNA-381 facilitates autophagy and apoptosis in prostate cancer cells via inhibiting the RELN-mediated PI3K/AKT/mTOR signaling pathway (Retracted article. See vol. 324, 2023)
Wenbiao Liao et al.
LIFE SCIENCES (2020)
FAM83A is amplified and promotes tumorigenicity in non-small cell lung cancer via ERK and PI3K/Akt/mTOR pathways
Haiyang Hu et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2020)
C1QTNF1-AS1 regulates the occurrence and development of hepatocellular carcinoma by regulating miR-221-3p/SOCS3
Hang Li et al.
HEPATOLOGY INTERNATIONAL (2019)
High expression of HMBOX1 contributes to poor prognosis of gastric cancer by promoting cell proliferation and migration
Nannan Diao et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
miR-221 Augments TRAIL-Mediated Apoptosis in Prostate Cancer Cells by Inducing Endogenous TRAIL Expression and Targeting the Functional Repressors SOCS3 and PIK3R1
Markus Krebs et al.
BIOMED RESEARCH INTERNATIONAL (2019)
Curcumin potentiates the galbanic acid-induced anti-tumor effect in non-small cell lung cancer cells through inhibiting Akt/mTOR signaling pathway
Qian Zhang et al.
LIFE SCIENCES (2019)
Syndecan-1 Controls Lung Tumorigenesis by Regulating miRNAs Packaged in Exosomes
Tanyalak Parimon et al.
AMERICAN JOURNAL OF PATHOLOGY (2018)
Low expression level of HMBOX1 in high-grade serous ovarian cancer accelerates cell proliferation by inhibiting cell apoptosis
Yun-Liang Yu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
miRNA-221 acts as an oncogenic role by directly targeting TIMP2 in non-small-cell lung carcinoma
Zijun Yin et al.
GENE (2017)
Exosomes derived from gemcitabine-resistant cells transfer malignant phenotypic traits via delivery of miRNA-222-3p
Feng Wei et al.
MOLECULAR CANCER (2017)
Knockdown of homeobox containing 1 increases the radiosensitivity of cervical cancer cells through telomere shortening
Shuliang Zhou et al.
ONCOLOGY REPORTS (2017)
MiRNA-21 induces epithelial to mesenchymal transition and gemcitabine resistance via the PTEN/AKT pathway in breast cancer
Zhen-Hua Wu et al.
TUMOR BIOLOGY (2016)
MicroRNA-101-3p reverses gemcitabine resistance by inhibition of ribonucleotide reductase M1 in pancreatic cancer
Pei Fan et al.
CANCER LETTERS (2016)
Exosomes Derived from Hypoxic Oral Squamous Cell Carcinoma Cells Deliver miR-21 to Normoxic Cells to Elicit a Prometastatic Phenotype
Ling Li et al.
CANCER RESEARCH (2016)
MiR-130a-3p regulates cell migration and invasion via inhibition of Smad4 in gemcitabine resistant hepatoma cells
Yang Liu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2016)
Curcumin inhibited HGF-induced EMT and angiogenesis through regulating c-Met dependent PI3K/Akt/mTOR signaling pathways in lung cancer
Demin Jiao et al.
MOLECULAR THERAPY-ONCOLYTICS (2016)
miR-222 Is Necessary for Exercise-Induced Cardiac Growth and Protects against Pathological Cardiac Remodeling
Xiaojun Liu et al.
CELL METABOLISM (2015)
Potent effect of adenoviral vector expressing short hairpin RNA targeting ribonucleotide reductase large subunit M1 on cell viability and chemotherapeutic sensitivity to gemcitabine in non-small cell lung cancer cells
Yoshimasa Tokunaga et al.
EUROPEAN JOURNAL OF CANCER (2015)
Pembrolizumab for the Treatment of Non-Small-Cell Lung Cancer
Edward B. Garon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Expression of EGFR Is Closely Related to Reduced 3-Year Survival Rate in Chinese Female NSCLC
Bing Li
MEDICAL SCIENCE MONITOR (2015)
Growth inhibitory effects of miR-221 and miR-222 in non-small cell lung cancer cells
Ryo Yamashita et al.
CANCER MEDICINE (2015)
Gemcitabine: Metabolism and molecular mechanisms of action, sensitivity and chemoresistance in pancreatic cancer
Lucas de Sousa Cavalcante et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
Extracellular vesicles: Exosomes, microvesicles, and friends
Graca Raposo et al.
JOURNAL OF CELL BIOLOGY (2013)
Exosomes Released by Melanoma Cells Prepare Sentinel Lymph Nodes for Tumor Metastasis
Joshua L. Hood et al.
CANCER RESEARCH (2011)
miR-221&222 Regulate TRAIL Resistance and Enhance Tumorigenicity through PTEN and TIMP3 Downregulation
Michela Garofalo et al.
CANCER CELL (2009)
Gastric cancer exosomes promote tumour cell proliferation through PI3K/Akt and MAPK/ERK activation
J. -L. Qu et al.
DIGESTIVE AND LIVER DISEASE (2009)
分享论文
